Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Arega Hovsepyan is our candidate for Chair of the Committee on European IntegrationThe Final Round of the Junius Tournament Has BegunAwards Ceremony for the “Top 100 Students of Armenia” Competition: Presentation of CertificatesNew Samsung Galaxy A27 as Part of Ucom’s Special “Back to School 2026” OfferMillennials, Gen Z, or Gen Alpha: How Different Generations Prepare for the New School Year: Idram&IDBankFinancial Literacy at the Republican Center for Children and Youth Tent Camp: Idram & IDBankUnlocking the Secrets of the Financial World at ''Hayordi'' Camp with Idram&IDBankUcom Supports the Second Phase of ArmDrone’s FPV Drone Educational Program "The Power of One Dram" to "Orran" Charitable Non-Governmental OrganizationUcom and Microsoft Innovation Center’s Cybersecurity Education Program Concludes with a Mini CTF CompetitionCustomer Appreciation Day - This Time at IDBank’s “Erebuni” BranchResults of the Junius Tournament Announced: The Next Round AheadUcom Expands International Roaming Capabilities"Urgently Confirm Your Card Details": IDBank Warns of Hotel Booking ScamsMher Ananyan joins Unibank's Management Board Ucom Supports the Launch of "Remember the Animals" Educational Game Moody’s changes the outlook on IDBank’s ratings to positive IDBank Introduces the New Mastercard World Card with Exclusive Travel Benefits and a Special Launch CampaignConverse Bank and Visa expand their strategic partnership to introduce new customer solutions Ucom and FPWC Ensure Round-the-Clock Wildlife Monitoring in Gnishik Through Solar Energy
All Timeline »
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.